GLP-1 vs Insulin Glargine

Head-to-head comparison of GLP-1 (Glucagon-like peptide-1 (7-36 amide)) and Insulin Glargine (Insulin glargine (A21Gly,B31Arg,B32Arg human insulin analog)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyGLP-1Insulin Glargine
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NameGlucagon-like peptide-1 (7-36 amide)Insulin glargine (A21Gly,B31Arg,B32Arg human insulin analog)
Molecular Weight3297 Da6063.6 Da
Half-Life1-2 minutesAbout 12-24 hours
Amino Acids3051
Typical DoseResearch-only: 0.1-1.0 pmol/kg/min0.1-0.2 U/kg once daily
RouteIntravenous/SubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count120013000
Research StatusPre-clinicalApproved

GLP-1 Benefits

  • beta-cell protection
  • improved insulin secretion
  • slower gastric emptying
  • lower postprandial glucose

Insulin Glargine Benefits

  • Once-daily basal coverage
  • Smooth action profile
  • Lower nocturnal hypoglycemia risk
  • Improves fasting glucose control

GLP-1 Dosing

0.1-1.0 pmol/kg/min IV infusion in research|0.5-10 nM in vitro|continuous delivery in animal studies

Insulin Glargine Dosing

Inject SC once daily at the same time each day|Titrate every 3-4 days to fasting glucose targets|Can be combined with prandial insulin

GLP-1 Side Effects

  • nausea at pharmacologic exposure
  • tachyphylaxis with continuous exposure
  • headache

Insulin Glargine Side Effects

  • Hypoglycemia
  • Injection-site reactions
  • Weight gain

Research Overview

GLP-1

Native GLP-1 has a very short half-life because of rapid DPP-4 cleavage, so it is mainly used as a mechanistic research peptide. Across animal and cellular studies it reduces beta-cell apoptosis, improves insulin gene expression, and enhances islet resilience.

Insulin Glargine

Clinical and translational studies support its use as a basal comparator because of prolonged absorption and stable glycemic control. It is heavily used in basal-bolus regimen research and insulin-delivery optimization studies.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

GLP-1 stacks with:

DPP-4 inhibitorsSGLT2 inhibitorsdiet and exercise

Insulin Glargine stacks with:

Insulin LisproInsulin Aspart
incretinbeta-cell survivalDPP-4 substratebasal insulinlong-actingfasting glucose